Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Critical Care Clinics|May 9, 2006
Drug-associated disease: hematologic dysfunctionErik R Vandendries, Reed E DrewsThrombosis and Haemostasis|September 8, 2004
Role of P-selectin and PSGL-1 in coagulation and thrombosisErik R Vandendries, Barbara C Furie, Bruce FurieProceedings of the National Academy of Sciences of the United States of America|December 28, 2006
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosisErik R Vandendries, Justin R Hamilton, Shaun R Coughlin, et al.Leukemia & Lymphoma|February 25, 2015
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphomaNina D Wagner-Johnston, Andrè Goy, Maria A Rodriguez, et al.The Lancet. Haematology|July 9, 2017
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE studyHagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, et al.Pageof 1